Genometry

About:

Genometry commercializes a genome-wide, high-throughput, gene-expression profiling method for pharmaceutical discovery applications.

Website: http://www.genometry.com

Twitter/X: genometry

Top Investors: Sands Capital Ventures

Description:

GENOMETRY, INC is a platform-technology company founded by a multidisciplinary team of genome scientists to commercialize a revolutionary genome-wide high-throughput low-cost gene-expression profiling method (L1000) for next-generation pharmaceutical discovery applications.

Total Funding Amount:

$3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2012-08-01

Contact Email:

info(AT)genometry.com

Founders:

Arvind Subramanian, Dave Peck, Willis Read-Button

Number of Employees:

1-10

Last Funding Date:

2012-09-21

IPO Status:

Private

Industries: